FDA Estimates Effort for Implementing Requirements for Medical Devices

GMP News
7 November 2007
 

FDA Estimates Effort for Implementing Requirements for Medical Devices

 
In a publication in the Federal Register, Vol 72, No 182, 20. Sept. 2007, pages 53774-53778 the US Food & Drug Administration (FDA) estimates the effort necessary to implement the requirements defined in 21 CFR 820. The estimate is broken down quite accurately to the single paragraphs of 21 CFR 820.

The US authority asks industry for feedback on the estimate’s accuracy. The poll is connected with the Paperwork Reduction Act from 1995. For roughly 9,000 firms the FDA expects the effort to sum up to three million hours. Interestingly, the authority also estimates that 650 new companies (marketing medical devices for the first time) will need 143,000 hours to develop records and procedures for the CGMP/QS regulation.

Resulting from requirements defined 21 CFR 820, the FDA further estimates that activities are distributed as follows:

  • Requirements related to manufacture specifications, process controls and „Device History Record“ (DHR) – 40%

  • Requirements related to components and acceptance activities – 20%

  • Requirements related to equipment, records, complaints including directly associated issues as well as labelling/packaging – 25%

  • Requirements related to quality audit, traceability, distribution, and statistics etc. – 15%.

Further information is available in the CFR Excerpt.

Author:
Sven Pommeranz
On behalf of the European Compliance Academy (ECA)
 

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK